Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i)
暂无分享,去创建一个
S. Brunton | P. Lefebvre | B. Bookhart | Willy Wynant | D. Pilon | M. Lafeuille | Rhiannon L. Kamstra | Heather M. Rozjabek | H. Rozjabek | W. Wynant